Bart van Hoek
0000-0001-6527-764X
Leiden University
14 papers found
Refreshing results…
Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030
Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease
Refitting the Model for End‐stage Liver Disease for the Eurotransplant region
Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study
Invited response to “MELD calibration”
Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region
Selected liver grafts from donation after circulatory death can be safely used for retransplantation – a multicenter retrospective study
The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by 99mTc-Mebrofenin hepatobiliary scintigraphy including SPECT and computed tomography in the risk prediction of postoperative mortality in ALPPS
Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation
Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study
Effects of preventive versus “on-demand” nutritional support on paid labour productivity, physical exercise and performance status during PEG-interferon-containing treatment for hepatitis C
Missing publications? Search for publications with a matching author name.